Trademark Overview
On Tuesday, April 30, 2024, a trademark application was filed for MOLECULERA BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the MOLECULERA BIOSCIENCES trademark a serial number of 98526774. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 30, 2024. This trademark is owned by Moleculera Biosciences, Inc.. The MOLECULERA BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Antibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes
Laboratory testing of materials; Medical and scientific research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Medical research laboratory services; Providing a website featuring educational information in the field of clinical research; Providing information about medical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Research laboratory analysis services in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment